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Cutaneous T-cell lymphoma (CTCL) may present 
with eczematous lesiol1S, mycosis fungoides (MF), or 
as exfoliative erythroderma with circulating atypical 
cells, Sezary syndrome (SS). The "malignant" T cells 
are epidermotropic and clonal, but whether they 
respond to antigen stimulation is unknown. Because 
CD4+ lymphocytes recognize antigen presented by 
histocompatibility locus antigen (HLA) class II mol-
ecules, and HLA associations have been found in 
autoimmune skin diseases, we detertnmed by allele-
specific oligonucleotide typing whether HLA-DR or 
DQ alleles were associated with CTCL and its two 
variants MF (n = 47) and SS (n = 23). Phenotypic 
frequencies were compared by chi-square and Fisher 
exact test, and p values were corrected independently 
for either 12 DR or 15 DQ alleles. HLA-DR5, previ-
ously associated with MF, was significantly increased 
in aU 70 CTCL patients (31.5%) ,'erslls controls (11%) 
(uncorrected p value [PI1J = 0.000038, odds ratio 
C utan eolls T-cell lymp homa (CTCL) (Wieselthi e r and Koh, 1990; Kuzel el ai, 1991 ; Abel el ai, 1993) has epide rmotropic atypical T lymphocytes of a h e lper-memory CD4+CD45Ro + phen otype (Sterry and Mielke, 1989) that arc c1 0nalJ y ex-
panded in skin lesions and blood (Weiss e/ ai, 1985, 1989; Michie c/ 
ai, 1989; Lessin e l ai, 1991; Wood cl ai, 1994; Bache lez (! I ai, 1.995; 
Gorochov et ai , 199 5) . A mixed inAammatory lymphocytic infiltTate 
is also present in skin les ions. T he m o lecular basis for tbe w ide 
c linical spectrllm of CTCL is not understood, ,]l though prognos tic 
fac tors have been identifi ed including age, dura tion of sympto m s, 
lympb node involvem ent, and circulating cells (Kim el ai, 1995). 
T he e pidemiologic data are contradic tory regarding a ro le fo r 
environmental facto rs (Fischmann el ai, 1979; Whittem o re el ai, 
1989; Teixeira c/ ai, 1994) . 
Tan et al (1974) hypothesized tha t CTCL arises fro m a state of 
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[OR] = 3.9, 1.9<OR<8.1), in MF patients (34%) (Pnc = 
0.000047, OR = 3.62,1.9<OR<10), and in SS patients 
(26%) (Pnc = 0.03, OR = 3, 0.9<OR<9.3). HLA-
DQBl*03 alleles (0301, 0302, and 0303) were in-
creased in 72% of aU CTCL patients "el'SIIS 49% of 
controls (corrected p value [PJ = 0.014, OR = 2.7, 
1.4<OR<5.1), in SS (82%) (Pc = 0.05, OR = 4.7, 
1.4<OR<5), and in MF (67%) (P"c = 0.024, OR = 2.15, 
1 < OR < 4.5). DQBl *0502 was strongly increased ill SS 
patients (Pc = 0.045, OR = 7.75, 1.25<OR<48). Al-
though HLA-DQBl*0603 and HLA-DR6 (1301, 1302, 
and 1402) were decreased in all groups, the decreases 
were not statistically significant. These data suggest 
that certain HLA-DRB and DQBl alleles, also asso-
ciated with other T -cell-mediated skin diseases, may 
participate in the pathogenesis of or susceptibility to 
CTCL. Key ",ords: IIIycosis jlllrgoides/Sez ary Srl/dr'ollle/ 
HLA disease association/cancel'. ] Itll1es t Dalllatof 107:373-
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persistent antigenic stimu lation . Recently, however, human T-cell 
lymphotrophic virus-l has been implicated in pathogenesis (Poiesz 
C( ai, 1980; Hall c/ ai, 199 1; Z ucker-Franklin e l (11, 1991, 1992 ; Kiss 
e/ (I I, 1992; Srivastava el ai, 1992; Ghosh el al. 1994; Te.ixeira el ai, 
1994; Pan cake cl ai, 1995) . T hese two hypoth eses may not be 
contradic to ry, as chronic v iral infection m ay result in antigenic 
stimulatio n . H e lper T lymph ocytes reace to antigen-bound histo-
compatibility locus antigen (HLA) class If molecul es and may do so 
even when th ey are expressed aberrantly o n epithe lial ce lls infected 
w ith v irus (Londei CI ai, 1984; Gregersen. 1989). A previolls report 
of an association of HLA-DR5 w ith m ycos is fungoides (M F) (Sa[1i 
cl ai, 1983) pro mpted LIS to de termine whethet· HLA-DRB or 
HLA-DQ alle les arc signifi c,llltly inc reased in MF and Sezary 
synd rol11e (SS) using more specifi c DNA-based m o lecul ar typ ing. 
The HLA cla ss II antigen associati on re po rted here suggests that the 
major H LAs may partic ipate in the pathogenesis of CTCL and that 
the disease might be 'lI1tigen driven. 
MATEJUALS AND METHODS 
Subjects Seventy consecutive C:llIcasinn subjects (4 '1 lIlales and 29 
(emales) with CTCL confi rmed by biopsy and skin examination gave verbal 
inlu nucd COllsent for venip unc ture and l-ILA typin g,. The researc h v,Ias 
approved by the Surve illance ComJ1littee for HUllt ;] n Subjects Resea rch. 
M.D. Anderson Cancer Cell te r. Diagnosis of MF was made on 47 patients 
based 0 11 biopsy and immullohistochemical evaluation of ski ll les ions 
showing atypical lymphocytes with CD4+ predominance and cpiderl11 O-
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Table I. HLA-DRBI Frequencies in CTCL Patients and Controls" 
CTCL (n = 70) MF (n = 47) SS (n = 23) 
HLA-DRB 
Alleles" 
DRI 
Frequ cncy 
28'}'0 (J 8) 
34%, (24) 
26'% (18) 
1" OR" Frcquency OR Frequency 
26% (6) 
43.5% (10) 
ny" (3) 
43 .5% (10) 
p' OR 
NormaL" (n = 2(0) 
Frequency 
DR.2 
DIU 
DR4 
D R5 ( 11 ) 
DI~6* 
31.5% (22) 
31 .5')1" (33) 
14% (10) 
7'X, (5) 
6% (4) 
1.5% (1) 
0'()00038 
0.5/0.044 
3 .91 
O.S 
25 .5'Y" (1 2) 
30'1., (14) 
32% (1 5) 
32% (12) 
34% (16) 
17% (8) 
O.O()()047 4.4 26'% (6) 
9% (2) 
9'1., (2) 
0% (0) 
0')1" (0) 
0.03 
0.710.06 
3.01 
0.3 
28% (56) 
30% (59) 
20%, (40) 
28% (55) 
11 % (21) 
26% (52) 
14% (27) 
11'X, (21) 
' 1301 
*'1302 
*1402 
DIU 
DRS 
D l~9 
DR10 
24% (17) 
9% (6) 
3% (2) 
1.5% (1) 
" Data arc presented as fj'cqucl1 cy (1'1). 
,. Ph enotypic and gcnotypjc frequenci es o f the DfU31 alle les. 
6% (3) 
8 .5'% (4) 
1% (1) 
27.5% (1 3) 
8.5% (4) 
0% (0) 
0'% (9) 
0 % (4) 
9% (2) 
9% (2) 
4% (1) 
2% (4) 
21% (4 1) 
9'% (18) 
2'% (4) 
0'1., (0) 
r p values ~I rc l':iOl corrct.: tcd. b;lscd 0 11 previo usly documented associ ation (Saf~1i ct 11/. 1983) for DR5 and arc g iven un corrected and corrected fo r Dlt6. W he n corrccl'Cd. th e 
p va lue is corrected hy mu lti plying by 'he nu", ber of alleles tested (12 " lIcles). 
II OR. odds ratio. 
"Rcvd Hc. cJ ti l, 1')92. 
tropism. Twenty-three pati" J1ts with exfoliati ve erythroderma, atypicaL 
lymphocytes in skin and peripheral blood, alld abnormal CD4:CD8 r iltios by 
Aow cytometry were classified as hav ing SS . He,dthy Callcasian controls 
(n = 200) who consented to have blood drawn were HLA typed as reported 
previoLlsly (ll.eveillc el fl l , 1992; Welsh " I nl, 1994). TN13M (Bu n.n and 
Lmnberg, 1979) staging was used to cl assify patients as having stage J or II 
MF (n = 43) or advanced-stage L11 Or LV MF or SS (n = 27). 
Preparation of DNA and Dot-Blot Analysis The HLA-DRBl and 
DQJ31 typ ing was perfoTllwd with genomic petiphcral blood DNA accord-
ing to the 1 '1 til HLA Internatiollal Workshop protocol with TAQ polymer-
asc (Cetus-Perkin-Elmer, Norwalk, CT) (R.evcillc cl nl , 1992; Welsh cl nl , 
1994). T he generic primers used to ampli fy the a/leles were: for DRB, 
D I~BAMP-A 5'-CCCCACAGCACGTTTCTTG-3' and D I~BAMP-B 5'-
CCGCTGCACTGTGAAG CTCT-3'; 'lJld for DQ13, DQI3AMI'-A 5'-
C ATGTGCTACTTCACCAACGG-3' and DQAMP-13 5'-CTGGTAGTT-
GTIGTGTCTGCACAC-3'. Conditions for DR-WI wcre 94°C X 1 min: 
then at 94 °C X 30 ,,55°C X '1 min , and 72°C X' I min X 35 cycles; ,md 
72°C X 7 ;llin. The HLA-DQBl locus was amplified at 94 °C X 30 s and 
then at 94°C X 30 s and 55°C X 30 s, with extension 'It 72°C for '1 min X 
35 cycles. Ampli fIed DNA on Zeta bind membran es (C uno, Meridian . CT) 
was hybridized with sequcnc"-spccific oligon ucleotide probes (R.evei lle e/ 
nl , 1992) at 54 °C fo r 1 to 3 h. Probes wcre end-labeled with [y-J2PjdATP 
(Amersham, Arlington , IL) and T4 polynucleotide kinase (USI3 Scientifics. 
Cleveland, 0 1-1 ) and were used at no kss th ,m 1 X 10" cpm p CI' n11 of 
hybridization so lu tion. T he membranes were washed in solu tions contain-
in g 3 M tetramethylammoni um chloride and 2 X SS PE and exposed to 
Kodak XA R-film at - 70°C overnight. 
Statistical Analysis Comp'lI'isons of H LA phenotypic frequencies be-
tween all patients or subgroups (MF and SS) !'ers lls normal controls were 
made by chi -square in 2 X 2 ta bles using the EPI-INFO statistica l program 
(USD. Inc., Stone Mountain . GA) . If fi ve or fewer patients wcrc consid-
ered, Fisher exact test was used. P vaJues were correc ted (pol by mul tiplying 
the p va lue by the number of allelic specificities we tested for e;lch DR or 
DQ locus separately, i.c., n = 12 for DIU31 and n = 15 for DQ131. We did 
nOt correct the p va lucs (P"e) fo r DR S because DRS W'IS pre viously 
associated with MF (Safai r l nl, 1983). O dds ra tios (O R.) and relati ve risks 
with exact confidence limits were determined. 
R ES ULTS 
Confirmation ofHLA-DR5 Association With CTCL and MF 
HLA-DRB l typing was performed on 69 CTCL patients: 47 with 
M F and 22 with SS, as shown in Table 1. J-ILA-DRB1 w11 (DRS) 
alle les were present in 3'1.5% of all CTCL patients compared with 
'11 '1., of white contro ls (P"c == 0.000038. OR = 3.9, 1..9 < OR< 8. 1) . 
HLA-DR5 was also significantly inc reased ill the MF subg ro up 
(34%) (P"e = 0 .000047, OR = 3.6, 12.9 < OR< 10) and in th e 
e rythrodcrmic S5 subgroup (26'0,) (Puc = 0.03, OR = 3 , 
O. 9 < O R < 9.3). 
HLA-DQBl * 03 Is Increased in CTCL, MF, and SS Patients 
Because alle les of HLA-DR13 are in linkage disequilibriul11 with 
HLA-DQ alle les, we next examined their frequ e n cy in the same 
subjects. Amo ng 70 CTCL patients, typing was ava ilable in 46 with 
MF and 22 with 5S, as sh own in Table II. DQBl *03 alle les as a 
whole (DQ "' 0301. 0302, and 0303) were significantly in creased in 
all CTCL patients and in S5 patients, and approached significance 
for the M F subset. At least one of the HLA-DQBl *03 alleles was 
pI'esen t in 72%, of aU CTCL patie n ts (Pc = 0.014, OR = 2.7 , 
1.4< OR< 5). in 82'Yo of 55 patients (Pc = 0.045. OR = 4 .7, 
1 .4 < 011..< 5), and in 67% of MF patients (Pnc == 0 .024, OR = 2 ,15, 
1 < 011..< 4 .5), compared with 49% o f Ca ucasian contro ls. 
DQBl*0502 Is Significantly Increased in SS Patients T h e 
strongest association was between DQB 1"'0502 and S5, whic h was 
found in 14'0, of t hese patients audin 2% of controls (Pc = 0.045, 
OR = 7 .75, 1 < OR< 48) . 
Negative Associations Are Also Suggested HLA-DR6 
(DOl, 1302, and 1402) al le les were present ill o nly 14% of all 
CTCL patients compared with 26% of white controls (Pol" = 0 .044, 
OR == 0.5 . 0.2 < OR< 1), and in 9% of the subset of MF patients 
compare d w ith 26% of white contro ls (POI" = 0 .06. OR = 0 .3. 
0.02 < OR < 0.9) if the p value was not co rrected . I-ILA-
DQBl *0603 was fO llnd in only 6% of th e CTCL patients, in 6 .5% 
of the MF patien ts, and in 4.5'% of the 55 patients lIerSIIS 17% in 
wh ite control s, with ORs at 0.24-0 .3 5. When corrected. however. 
the p va lues w e re not significant. T hese preliminary data suggest 
that a larger numbe r of patients m ay confirm negative association.s 
of CTCL with BLA-DR6 and HLA-DQBl *0603 alleles. 
HLA Associations Are Not Affected by Stage of Disease 
Dividing the patients into stage 1-11 or stage Ill-IV did not change 
the conclusio ns for the fj'equen cy of BLA a lle les studied (data not 
shown). 
HLA-DR or DQ Homozygosity Is Not Increased in CTCL 
and Its Variants Homozygosity for <1 lleles of the major histo-
compatibi li ty complex region has bee n reported to be associated 
w ith a uto immun e diseases sll ch ;IS systemic lupLls er yth ematosus 
(Skarsvag el (I I, 1992) .111d with <1 decrease in natural kille r activi ty, 
wh ic h mig ht be cri t ica l in the development of ll1 'll ig nancy (Dube), 
el nl, 1987). T here fore, we examined the preva le nce of homozy-
gosity at HLA loci in o ur CTCL population . Two MF patients w ere 
h omozygous for HLA-DR4, and 1 S5 patie n t was homozygous for 
J-ILA-DR2. T hese Ilumbe rs were not diffe ren t fwm those of the 
HLA-DR h omozygotcs in the contro l group . Two M F patients 
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Table ll. HLA-DQBl Frequencies in CTCL, MF, and SS Patients and Controls" 
C TCL (n = 68) MF (n = 46) SS (n = 22) 
HLA-DIU3 Normal" (n = 200) 
A ll e les" Frequen cy pC OR" Freq uenc y p" OR Frequen cy pC OR Freque n cy 
DQBl ' 0201 44'% (30) 50% (23) 32':;. (7) 36% (72) 
DQBl ' 03 72% (49) 0.0 14/ 0.00096 2.7 67'X. (31) 0.36 / 0.024 2.15 82% (18) 0.05 / 0.0034 4.7 49% (98) 
' 0301 37% (25) 39%, (18) 32% (7) 27% (54) 
' 0302 25% (17) 19.5% (9) 36'X, (8) 17% (34) 
' 0303 1O'x. (7) 9°A, (4) 14% (3) 5% (10) 
DQBl ' 0401 0% (9) D'Yo, (9) 0% (9) 0% (0) 
DQBl ' 0402 9% (6) 11 % (5) 4.5% (1) 7% (14) 
DQB1 ' 0501 25% (17) 24% (11) 27% (6) 29% (58) 
DQBl ' 0502 7.5% (5) 4% (2) 14% (3) 0.045/ 0.003 7.75 2% (4) 
DQBl ' 0503 0% (0) O'x. (0) 0% (0) 4% (81) 
DQB1 *0504 O'X, (9) 0% (0) 0% (0) 0% (0) 
DQB1 ' 0601 1.5% (1) 2% (1) 0% (0) 3% (5) 
DQBl ' 0602 29.5% (20) 26% (12) 36% (8) 26% (52) 
DQB1 ' 0603 6% (4) 0.42/ 0.028 0.32 6.5% (3) 1 .26 / 0.084 0.35 4.5% (1) 1 .95 / 0.13 0.24 17% (33) 
DQB1 ' 0604 6% (4) 9% (4) 0% (0) 11 % (22) 
DQB1 ' 0605 0% (0) 0% (0) 0% (0) 0% (0) 
(I Data [ll'e presented as fi'cqucncy (11). 
b Phenotypic and genot)'pic freq uencies of the DQn 1 alleles. 
r p values arc giver! uncorrected ;1I1d corrected. When applicable. lhe p value is corrected by the number of alleles tested (15 alle les). 
If OR, odds ratio. 
' Reveille el III , 1992. 
were homozygous for DQB1 *0602 and DQB1 · 0302. On the other 
hand, onJy two CTCL patients were homozygous for both DRB 
and DQB all eles, compared with 22 in the control population. 
DISCUSSION 
We examined the hypothesis that there is an immunogenetic basis 
to the pathogenesis of CTCL by investigating the frequency of class 
II antigens in patients. CTCL involves the proliferation ofCD4+ T 
cells that normally recognize antigenic peptides bound to specifi c 
epitopes of class II molecules on antigen-presenting cells . It has 
been suggested that the major hjstocompatibility complex class II 
genes may contribute to this disease, as well as to other autoim-
mune diseases (Sinha et ai, 1990). Class II antigens are het-
erodimeric transmembrane glycoproteins composed of alpha and 
beta chains. Tbeir variable domains are highly polymorphic with 
specific detenninants (Spies el ai, 1985; Jonsson et ai, 1987; 
Trowsdale et ai, 1991). Three subsets of class II antigens-DR, DQ, 
and DP-have been identified and ass igned to the I-ILA-D region 
on human chromosome 6. 
Early reports of class I HLA associations in patients with MF 
(MacKie e/ ai, 1976) were not confirmed by later stud ies (Ryder e/ 
aI, 1979), but a study of76 MF patients reported that the HLA class 
II DRS allele was increased, as assessed by traditional typing (Saf:1j 
ef ai, 1983). Our study used molecular DNA typin g to confirm the 
DRS (DRBl *11) association in a different group of American 
CTCL patients (Safai e/ Iii, 1983). Whethet· one of the subtypes of 
HLA-DR5 (DRBI *1101-1104) is prevalent in CTCL has yet to be 
determined. Because M F and SS have different cLin ical presenta-
tions and prognosis (Kim e/ ai, 1995), we also examined HLA-
DRB! and HLA-DQBl fi'cquencies in these two subsets of sub-
jects. HLA-DR5 was increased in both MF and SS patients. and 
HLA-DQB1 ' 03 alleles were increased signifi cantly eve n in this 
small study of23 SS patients. T he most significant associations were 
between SS and DQB1 *0502. T he frequencies of HLA-D.R. and 
HLA-DQB1 alleles in our control population were similar to those 
reported in the li terature (PllI'k and Tonai, 1992). Grouping of 
patients according to stage of disease did not change the conclu-
sions. We found no difference in homozygosity between our CTCL 
patients and the control group. 
When DQBl *03 specificities were considered as a group. they 
were present in 72% of all CTCL patients and in 82'1., ofSS patients, 
with an OR of 2.7 and 4.7, respectively. These three aJleles share 
a prollile residue at position 55 that may influcnce heterorumer 
formation with DQA chains (Park and Tonai, 1992; Welsb et ai, 
1994). It is intriguing that DQBl *03 alleles are also increased 
among patients with T-cell-mediated "autoimmune" skin diseases. 
Both HLA-DR11(DRS) and the group of DQB1 *03 alleles are 
increased in patients with alopecia areata and totalis (Duvic el ai, 
1991; Welsh et ai, 1994), which are characterized by follicular 
T -cell infiltrates. The same histologic pattem is present in two of 
the MF variants, follicular mucinosis and alopecia mucinosa. HLA-
DQB 1 *03 alleles are also signiflcantly increased in patients ,!Vith an 
anti-centromere antibody response in scleroderma (Reveille el ai, 
1992) and in patients with cutaneous melanoma in association with 
poor outcome (Lee et ai , 1994). Of interest, serum antibodies to 
melanocytes are found in alopecia areata (Tobin et ai, 1994) and in 
vitiligo (Naughton e/ ai, 1983), and such antibodies are associated 
with improved survival in melanoma. 
HLAs are implicated in the pathogenesis of both systemic and 
organ-specific autoimm une diseases (Sinha ef ai, 1990). HLA class II 
associations are thought to arise £i'om cri tica l amino acid residues 
that influencc peptide binding or interactions with T-cell receptor 
or HLA chains (Sinha ef ai, 1990). In autoimmune diseases iJ1c1ud-
ing psoriasis, rheumatoid artluitis, and even alopecia arcata, specific 
T-cell clones have been detected in lesions (Stamenkovic el ai, 
1988; W eyland e/ (If, 1992; C hang e/ ai, 1994; Szafel' el ai, 1995). An 
antigen-"stitlluJated" T-cell clone tllay be indistinguishable from a 
"m~lignant" T-cell lymphoma clone. Both may be HLA restricted 
and cause cutaneous inflammation. 
T he HLA class II associations for CTCL support the previous 
hypothesis that CTCL is a disease of antigen persistence (Tan e/ ai, 
1974) . D istinguishing "antigen persistence" from an imtllune/ 
"autoimmune" reaction to a cell subclinically infected with a virus 
may prove as difficult as knowing exactly when a predominantly 
inflammatory T-cell infi ltrate has crossed tile border ii-om c10nality 
to ma lignancy. 
T /, is stlld), ",a"ji llIJed ill pm111mllls il a PII),sirialls ' R~relml Grnlll, IVf.D. A "dcn''' '' 
Callcel' CClllel', mil/ FOIII iValillltnl IIISlilllie ~r An/llitis ntId MlIsw/oskdcltI/ flI ld 
Ski//. Diseases CI'tIllI A R 39915. Hi e ncklloll'/edS" Ille denlla/cl/os), residellis ' IIe1p ill 
co/leelillg !laticllI samples. 
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